Related Experiment Videos
[Mastoscopic axillary lymph node dissection for the patients with breast cancer]
Cheng-yu Luo1, Jian Zhang, Hua Lin
1Beijing Fuxing Hospital, Capital University of Medical Science, Beijing 100038, China.
Objective:
To analyze the clinical effects of mastoscopic axillary lymph node dissection for the patients with breast cancer.
Methods:
Following the liposuction of the axilla, axillary lymph node dissection was performed in 86 breast cancer patients by mastoscopy.
Results:
The median duration of operation was 55.3 min. The operation time was obviously shorter for the last 76 patients than for the first 10 patients (P < 0.001). The bleeding amount in operation was little, and no patient was intraoperatively transferred to routine open axillary lymph node dissection due to uncontrolled bleeding. A mean number of 15.3 lymph nodes were harvested. 37 patients showed involved lymph nodes. The mean number of involved lymph nodes in these patients was 3.6. There was no intra- and post-operation morbidity. After a median follow-up time of 10.4 months, no axillary relapse or trocar site implantation had occurred.
Conclusion:
Mastoscopic axillary lymph node dissection (MALND) based on the liposuction of axilla is a minimally invasive and clinical feasible procedure. It manifests the functional and cosmetic effects and satisfies the breast cancer patients to certain extent.